029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
FMG1003b乳腺癌多病理类型组织组合芯片,附病理分级、TNM和临床分期,47例/101点,替代BR1003a
点 数101例 数47
行 数10列 数11
点直径(mm)1.0厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:FMG1003b
 
乳腺癌多病理类型组织组合微阵列芯片,包含增生、导管上皮内瘤变、浸润性导管癌和浸润性小叶癌各10例,一例两点,尸解乳腺组织7例,一例三点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Bre
-Breast
 
Hyperplasia (*)
 
Malignant (IIA)
 
Malignant (IIB)
 
Malignant (IIIA)
 
Malignant (IIIB)
 
Normal (*)
TISSUE  ARRAYS FMG1003b
1
2
3
4
5
6
7
8
9
10
11
A
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
B
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
C
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
D
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
E
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
F
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
G
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
H
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
I
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
BRE
J
BRE
BRE
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeisBackUp
A1149FBreastAdenosis***HyperplasiaN
A2249FBreastAdenosis***HyperplasiaN
A3342FBreastAdenosis***HyperplasiaN
A4442FBreastAdenosis***HyperplasiaN
A5537FBreastAdenosis***HyperplasiaN
A6637FBreastAdenosis***HyperplasiaN
A7741FBreastAdenosis***HyperplasiaN
A8841FBreastAdenosis***HyperplasiaN
A9944FBreastAdenosis***HyperplasiaN
A101044FBreastAdenosis***HyperplasiaN
A111140FBreastAtypical hyperplasia***HyperplasiaN
B11240FBreastAtypical hyperplasia***HyperplasiaN
B21341FBreastAdenosis***HyperplasiaN
B31441FBreastAdenosis***HyperplasiaN
B41546FBreastAdenosis***HyperplasiaN
B51646FBreastAdenosis***HyperplasiaN
B61738FBreastAdenosis***HyperplasiaN
B71838FBreastAdenosis***HyperplasiaN
B81948FBreastAdenosis***HyperplasiaN
B92048FBreastAdenosis***HyperplasiaN
B102156FBreastDuctal intraepithelial neoplasia (DIN I)***HyperplasiaN
B112256FBreastDuctal intraepithelial neoplasia (DIN I)***HyperplasiaN
C12346FBreastDuctal intraepithelial neoplasia (DIN III)***HyperplasiaN
C22446FBreastDuctal intraepithelial neoplasia (DIN III)***HyperplasiaN
C32549FBreastDuctal intraepithelial neoplasia (DIN II)***HyperplasiaN
C42649FBreastDuctal intraepithelial neoplasia (DIN I)***HyperplasiaN
C52748FBreastDuctal intraepithelial neoplasia (DIN I)***HyperplasiaN
C62848FBreastDuctal intraepithelial neoplasia (DIN I)***HyperplasiaN
C72954FBreastDuctal intraepithelial neoplasia (DIN I)***HyperplasiaN
C83054FBreastDuctal intraepithelial neoplasia (DIN II)***HyperplasiaN
C93149FBreastDuctal intraepithelial neoplasia with early infiltration (DIN III)***HyperplasiaN
C103249FBreastDuctal intraepithelial neoplasia with early infiltration (DIN III)***HyperplasiaN
C113344FBreastDuctal intraepithelial neoplasia (DIN II)***HyperplasiaN
D13444FBreastDuctal intraepithelial neoplasia (DIN II)***HyperplasiaN
D23553FBreastDuctal intraepithelial neoplasia (DIN II)***HyperplasiaN
D33653FBreastDuctal intraepithelial neoplasia (DIN II)***HyperplasiaN
D43744FBreastDuctal intraepithelial neoplasia (DIN II)***HyperplasiaN
D53844FBreastDuctal intraepithelial neoplasia (DIN III)***HyperplasiaN
D63944FBreastDuctal intraepithelial neoplasia (DIN III)***HyperplasiaN
D74044FBreastDuctal intraepithelial neoplasia (DIN III)***HyperplasiaN
D84175FBreastInvasive carcinoma of no special type1--2T3N1M0IIIAMalignantN
D94275FBreastInvasive carcinoma of no special type1--2T3N1M0IIIAMalignantN
D104351FBreastInvasive carcinoma of no special type2T2N2M0IIIAMalignantN
D114451FBreastInvasive carcinoma of no special type2T2N2M0IIIAMalignantN
E14543FBreastInvasive carcinoma of no special type2T3N0M0IIBMalignantN
E24643FBreastInvasive carcinoma of no special type2T3N0M0IIBMalignantN
E34732FBreastInvasive carcinoma of no special type2T3N1M0IIIAMalignantN
E44832FBreastInvasive carcinoma of no special type2T3N1M0IIIAMalignantN
E54987FBreastInvasive carcinoma of no special type2T2N1M0IIBMalignantN
E65087FBreastInvasive carcinoma of no special type2T2N1M0IIBMalignantN
E75143FBreastInvasive carcinoma of no special type2T4N1M0IIIBMalignantN
E85243FBreastInvasive carcinoma of no special type2T4N1M0IIIBMalignantN
E95348FBreastInvasive carcinoma of no special type2T2N2M0IIIAMalignantN
E105448FBreastInvasive carcinoma of no special type2T2N2M0IIIAMalignantN
E115547FBreastInvasive carcinoma of no special type2T4N0M0IIIBMalignantN
F15647FBreastInvasive carcinoma of no special type2T4N0M0IIIBMalignantN
F25750FBreastInvasive carcinoma of no special type2T2N0M0IIAMalignantN
F35850FBreastInvasive carcinoma of no special type2T2N0M0IIAMalignantN
F45958FBreastInvasive carcinoma of no special type2T3N1M0IIIAMalignantN
F56058FBreastInvasive carcinoma of no special type2T3N1M0IIIAMalignantN
F66142FBreastInvasive lobular carcinoma*T2N1M0IIBMalignantN
F76242FBreastInvasive lobular carcinoma*T2N1M0IIBMalignantN
F86347FBreastInvasive lobular carcinoma*T2N1M0IIBMalignantN
F96447FBreastInvasive lobular carcinoma*T2N1M0IIBMalignantN
F106541FBreastInvasive lobular carcinoma*T4N0M0IIIBMalignantN
F116641FBreastInvasive lobular carcinoma*T4N0M0IIIBMalignantN
G16745FBreastInvasive lobular carcinoma*T2N0M0IIAMalignantN
G26845FBreastInvasive lobular carcinoma*T2N0M0IIAMalignantN
G36958FBreastInvasive lobular carcinoma*T2N0M0IIAMalignantN
G47058FBreastInvasive lobular carcinoma*T2N0M0IIAMalignantN
G57138FBreastInvasive lobular carcinoma*T2N0M0IIAMalignantN
G67238FBreastInvasive lobular carcinoma*T2N0M0IIAMalignantN
G77351FBreastInvasive lobular carcinoma*T4N0M0IIIBMalignantN
G87451FBreastInvasive lobular carcinoma*T4N0M0IIIBMalignantN
G97542FBreastInvasive lobular carcinoma*T3N0M0IIBMalignantN
G107642FBreastInvasive lobular carcinoma*T3N0M0IIBMalignantN
G117751FBreastInvasive lobular carcinoma*T2N1M0IIBMalignantN
H17851FBreastInvasive lobular carcinoma*T2N1M0IIBMalignantN
H27969FBreastInvasive lobular carcinoma*T2N0M0IIAMalignantN
H38069FBreastInvasive lobular carcinoma*T2N0M0IIAMalignantN
H48121FBreastBreast tissue***NormalN
H58221FBreastBreast tissue***NormalN
H68321FBreastBreast tissue***NormalN
H78419FBreastBreast tissue***NormalN
H88519FBreastBreast tissue***NormalN
H98619FBreastBreast tissue***NormalN
H108721FBreastBreast tissue***NormalN
H118821FBreastBreast tissue***NormalN
I18921FBreastBreast tissue***NormalN
I29027FBreastBreast tissue***NormalN
I39127FBreastBreast tissue***NormalN
I49227FBreastBreast tissue***NormalN
I59350FBreastBreast tissue***NormalN
I69450FBreastBreast tissue***NormalN
I79550FBreastBreast tissue***NormalN
I89650FBreastBreast tissue***NormalN
I99750FBreastBreast tissue***NormalN
I109850FBreastBreast tissue***NormalN
I119949FBreastBreast tissue***NormalN
J110049FBreastBreast tissue***NormalN
J210149FBreastBreast tissue***NormalN
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情